Literature DB >> 25362198

Application of Frontal Affinity Chromatography to Study the Biomolecular Interactions with Trypsin.

YuanYuan Hu1, Junqing Qian2, Hui Guo1, ShengLan Jiang1, Zheng Zhang1.   

Abstract

Trypsin is a serine protease that has been proposed as a potential therapeutic target for metabolic disorders and malignancy diseases, thus the identification of biomolecular interactions of compounds to trypsin could be of great therapeutic importance. In this study, trypsin was immobilized on a monolithic silica capillary column via sol-gel. The binding properties of four small molecules (daidzin, genistin, matrine and oxymatrine) to trypsin were examined using the trypsin affinity columns by frontal analysis. The results indicate that the matrine (dissociation constant, Kd = 7.904 μM) has stronger interaction with trypsin than the oxymatrine (Kd = 8.204 μM), whereas daidzin and genistin were nearly have no affinity with trypsin. The results demonstrated that the frontal affinity chromatography can be used for the direct determination of protein-protease inhibitor binding interactions and have several significant advantages, including easy fabricating, reproducible, minimal technological requirements and potential to become a reliable alternative for quantitative studies of biomolecular interactions.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25362198     DOI: 10.1093/chromsci/bmu141

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  2 in total

Review 1.  Affinity monolith chromatography: A review of general principles and recent developments.

Authors:  Saumen Poddar; Sadia Sharmeen; David S Hage
Journal:  Electrophoresis       Date:  2021-08-12       Impact factor: 3.595

2.  Matrine Directly Activates Extracellular Heat Shock Protein 90, Resulting in Axonal Growth and Functional Recovery in Spinal Cord Injured-Mice.

Authors:  Norio Tanabe; Tomoharu Kuboyama; Chihiro Tohda
Journal:  Front Pharmacol       Date:  2018-05-07       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.